-

Shareholder Alert: Robbins LLP Is Investigating the Officers and Directors of VMware, Inc. (VMW)

SAN DIEGO & PALO ALTO, Calif.--(BUSINESS WIRE)--Shareholder rights law firm Robbins LLP announces that it is investigating the officers and directors of VMware, Inc. (NYSE: VMW) for breaches of fiduciary duties, unjust enrichment, waste of corporate assets, and violations of the Securities Exchange Act of 1934. VMware provides software in the areas of hybrid cloud, multi-cloud, modern applications, networking and security, and digital workspaces.

If you suffered a loss as a result of VMware's misconduct, click here.

VMware, Inc. (VMW) Accused of Misleading Investors

One of the financial metrics VMware regularly reports is its backlog, which the Company purports is comprised of “unfulfilled purchase orders or unfulfilled executed agreements at the end of a given period.” Between March 2019 and February 2020, VMware reported hundreds of millions of dollars in backlog in a series of press releases and financial reports, each time attesting to the accuracy of the Company's financial reporting as well as its maintenance of effective internal control over financial reporting. Then, on February 27, 2020, VMware disclosed that the SEC was conducting an investigation into the Company's backlog and associated accounting and disclosures. VMware reported that it was “fully cooperating with the SEC’s investigation and is unable to predict the outcome of this matter at this time.” On this news, VMware stock fell $15.11 per share, or more than 11%, to close at $120.52 per share.

VMware, Inc. (VMW) Shareholders Have Legal Options

Contact us to learn more:
Leo Kandinov
(800) 350-6003
LKandinov@robbinsllp.com
Shareholder Information Form

Want to be notified if a class action against VMware settles? Want to receive free alerts about companies engaged in wrongdoing? Sign up for Stock Watch today.

Attorney Advertising. Past results do not guarantee a similar outcome.

Contacts

Leo Kandinov
Robbins LLP
LKandinov@robbinsllp.com
(619) 525-3990 or Toll Free (800) 350-6003
www.robbinsllp.com

More News From Robbins LLP

Investor Notice: Robbins LLP Informs Investors of the FS KKR Capital Corp. Class Action

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP informs stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired FS KKR Capital (NYSE: FSK) securities between May 8, 2024 and February 25, 2026. FS KKR Capital is a private credit firm, also known as Business Development Company, which specializes in making private loans to companies.For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003.The Allegations: Ro...

Robbins LLP Urges GOSS Stockholders to Contact the Firm for Information About the Class Action Against Gossamer Bio, Inc.

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Gossamer Bio, Inc. (NASDAQ: GOSS) securities between June 16, 2025 and February 20, 2026. Gossamer is a clinical stage biopharmaceutical company focused on the development and commercialization of seralutinib for the treatment of pulmonary hypertension (PH) associated with interstitial lung disease.For more information, submit a form, email att...

Robbins LLP Urges IBRX Stockholders to Contact the Firm for Information About the Class Action Against ImmunityBio, Inc.

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired ImmunityBio, Inc. (NASDAQ: IBRX) securities between January 19, 2026 and March 25, 2026. ImmunityBio is a biotechnology company and ANKTIVA is the Company's lead biologic product. For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003. What is the class period? January 19, 2026 – March 25, 202...
Back to Newsroom